eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2006
vol. 10
 
Share:
Share:
abstract:

The role of hormone replacement therapy and the risk of development of ovarian cancer

Lubomir Bodnar
,
Agnieszka Gąsowska-Bodnar
,
Cezary Szczylik

Współcz Onkol (2006) vol. 10; 1 (28–33)
Online publish date: 2006/02/22
View full text Get citation
 
Hormone replacement therapy (HRT), which is mainly used to relieve climacteric symptoms, increases a woman’s risk for breast cancer, uterine endometrial cancer, but the association with ovarian cancer is less clear. Based upon epidemiological research there is evidence that steroids hormones, primarily estrogens and progesterone have an impact on ovarian carcinogenesis. The latest data have indicated that estrogens favour neoplastic transformation within the ovarian surface epithelium. There has been demonstrated a differential expression of ER alpha or beta during ovarian carcinogenesis, with an overexpression of ER alpha as compared with ER beta in cancer. The loss of ER-beta expression may be an important event leading to the development of ovarian cancer. ER- beta is a regulator of proliferation and motility of ovarian cancer cells. On the other hand, high progesterone levels offer a protection against development of ovarian carcinoma and overexpression progesterone receptors, which in turn, is associated with favourable prognosis in patients with ovarian cancer. Recent prospective epidemiological studies have indicated that hormone replacement therapy in post menopausal women may increase ovarian cancer incidence and mortality, especially in the group of women who have undergone HRT for more than 10 years. Physicians counselling women about HRT must consider the unique needs of each patient, and attempt to weigh the benefits and risks on an individual basis.
keywords:

hormone replacement therapy, ovarian cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.